SARS-CoV-2 associated viral encephalitis with mortality outcome
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) appeared in Wuhan, China, in December 2019; apart from common conditions such as cough, fever, and severe respiratory complications, difficulty in breathing, including tachypnea, new studies on neurological manifestations have...
Main Authors: | Mohammed A. Azab, Ahmed Y. Azzam |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Interdisciplinary Neurosurgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221475192100044X |
Similar Items
-
Encephalitis associated with the SARS-CoV-2 virus: A case report
by: Fenne Vandervorst, et al.
Published: (2020-12-01) -
Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19
by: Chia, Y.K, et al.
Published: (2021) -
Autoimmune limbic encephalitis related to SARS-CoV-2 infection: Case-report and review of the literature
by: Chiara Pizzanelli, et al.
Published: (2021-03-01) -
Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19
by: Chia, YK, et al.
Published: (2021) -
In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)